Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2009
07/09/2009US20090176692 Amidated insulin glargine
07/09/2009US20090176290 Bacillus Host Cell
07/09/2009US20090176279 Bioreactive agents
07/09/2009US20090176276 Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide
07/09/2009US20090176275 Expression system, components thereof and methods of use
07/09/2009US20090176274 Glycosylated mammalian ngal and use thereof
07/09/2009US20090176273 Production of Lipidated Proteins In E. coli
07/09/2009US20090176272 Expression of nucleic acid sequences for production of biofuels and other products in algae and cyanobacteria
07/09/2009US20090176254 Mammalian galanin receptors
07/09/2009US20090176246 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES
07/09/2009US20090176219 Dna binding site of a transcriptional activator useful in gene expression
07/09/2009US20090176217 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
07/09/2009US20090176209 Selection
07/09/2009US20090176205 Mutant proteins in the dna-binding domain of a telomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna
07/09/2009US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
07/09/2009US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization
07/09/2009US20090175893 Albumin-Fused Anti-Angiogenesis Peptides
07/09/2009US20090175881 Interleukin-17A specific immunoglobulin for use in prevention and treatment of inflammatory, autoimmune and proliferative disorders
07/09/2009US20090175876 Methods of using phhla2 to co-stimulate t-cells
07/09/2009US20090175871 Method for demonstrating presence or absence of markers associated with the presence and/or the chemosensitivity of tumors
07/09/2009US20090175867 Single-Chain Multivalent Binding Proteins with Effector Function
07/09/2009US20090175851 Bivalent, bispecific antibodies
07/09/2009US20090175850 NOGO Receptor Homologs
07/09/2009US20090175847 Humanized antibodies to ab (20-42) globulomer and uses thereof
07/09/2009US20090175844 Method of diagnosing bladder cancer
07/09/2009US20090175828 Coagulation Factor X Polypeptides With Modified Activation Properties
07/09/2009US20090175795 Chimeric therapeutic agents
07/09/2009US20090175784 Anti-Alpha V Immunoliposome Composition, Methods, and Uses
07/09/2009CA2709890A1 Cell culture processes
07/09/2009CA2705925A1 Yeast strains for protein production
07/08/2009EP2077325A1 Monoclonal antibody and use thereof
07/08/2009EP2077282A2 Antigen binding molecules with increased Fc receptor binding affinity and effector function
07/08/2009EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof
07/08/2009EP2077275A2 IgA nephropathy-related DNA
07/08/2009EP2077121A1 Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder
07/08/2009EP2077120A2 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient
07/08/2009EP2076604A2 Glp-2 mimetibodies, polypeptides, compositions, methods and uses
07/08/2009EP2076596A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
07/08/2009EP2076542A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers
07/08/2009EP2076529A1 Antibacterial and antiviral peptides from actinomadura namibiensis
07/08/2009EP2016194A4 Methods and compositions for expressing negative-sense viral rna in canine cells
07/08/2009EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene
07/08/2009EP1360281B1 Regulation of human wee1-like serine/threonine protein kinase
07/08/2009EP1281759B1 Method of inhibiting the formation of by-product in the production of genetically modified polypeptide
07/08/2009EP0669988B2 Angiogenesis inhibitory antibodies
07/08/2009CN101475975A Purification method for producing alpha-interferon
07/08/2009CN100510096C Promotor for expressing gene in fungal cell
07/08/2009CN100510095C Method for producing polypeptide in bacillocin cell
07/08/2009CN100510084C Nucleic acid constructs and methods for producing altered seed oil compositions
07/08/2009CN100510073C Tryptase inhibitor
07/08/2009CN100510068C A soluble complex comprising a retroviral surface glycoprotein
07/08/2009CN100509837C Clone, expression and biological activity of stingray caudal spine cyclophilin A gene
07/08/2009CN100509836C Clone, expression and biological activity of stingray tumor suppressor gene
07/07/2009USRE40831 Passive immunotherapy; hybridoma cell line and antibodies produced by the cell lines; prevention and treatment of HBV infection
07/07/2009US7557194 Antibody materials for an IBD-associated polypeptide
07/07/2009US7557192 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders
07/07/2009US7557190 Epithelial cell adhesion molecule (Ep-CAM) antibodies; cytotoxic chemotherapeutics; antitumor agents
07/07/2009US7557189 Immunoconjugates; screening for antibodies with improved affinity to CD 33 antigen; diagnosis of chronic myeloid leukemia (CML) and promyelocytic leukemia (PML); treating cancer
07/07/2009US7557187 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins
07/07/2009US7557185 Moraxella catarrhalis proteins
07/07/2009US7557182 Drug delivery across the blood-brain barrier using polypeptides; neurological diseases; aprotinin
07/07/2009US7557083 Gastrokines and derived peptides including inhibitors
07/07/2009US7557068 Evolving new molecular function
07/07/2009US7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
07/07/2009US7556960 Pseudomycin production by pseudomonas syringae
07/07/2009US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy
07/07/2009US7556955 Nucleic acids encoding Candida kefyr cytosine deaminase
07/07/2009US7556953 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an N-terminal leader sequence
07/07/2009US7556952 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of a known amino acid sequence and an initial N-terminal residue
07/07/2009US7556951 Bioactive ribonucleases for treating tumors in humans
07/07/2009US7556942 Genes in cancer and polynucleotides with codes for polypeptides with amino acid sequences
07/07/2009US7556941 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals
07/07/2009US7556940 Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
07/07/2009US7556939 As a target for drug development against Chagas' disease; TcPRAC genes in T. cruzi encode functional intracellular or secreted versions of the enzyme exhibiting distinct kinetic properties that may be relevant for their relative catalytic efficiency
07/07/2009US7556928 Using biotin matrix to confine and analyze cell and its secretory components in microdrop; gel microdrop (GMD) secretion assay
07/07/2009US7556816 Microbiocides, bactericides
07/07/2009US7556815 Mutant viral antigen for use in diagnosing hepatitis; immunoassay
07/07/2009US7556807 Streptococcus mutans competence stimulating peptide (CSP) which inhibits biofilm formation; dental carries, periodontal disease, gingivitis, and endocarditis; inhibiting dental plaque formation
07/07/2009US7556805 Compositions for treatment of melanoma and method of using same
07/07/2009US7556804 Monoclonal antibodies which recognize the chain of hepatocyte growth factor receptor (HGF) receptor with the agonist activity of the natural ligand; hybridoma and the antibodies it secretes; inhibiting apoptotic damage to cells ; cardioprotective and hepatoprotective drugs
07/07/2009CA2415990C Method for producing biologicals in protein-free culture
07/07/2009CA2353909C Betacellulin muteins
07/07/2009CA2167692C Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
07/02/2009WO2009082398A1 Antibacterial compounds and methods of using same
07/02/2009WO2009081955A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa
07/02/2009WO2009080299A1 Sm-protein based secretion engineering
07/02/2009WO2009079922A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof
07/02/2009WO2008058380A8 Cancerous disease modifying antibodies
07/02/2009WO2007090675A8 Novel oxidoreductases and uses thereof
07/02/2009US20090172835 Flax (linum usitatissimum l.) seed-specific promotors
07/02/2009US20090171070 Process for the Purification of Recombinant Albumin
07/02/2009US20090170800 Genetic constructs and compositions comprising rre and cte and uses thereof
07/02/2009US20090170775 Vasoactive intestinal polypeptide compositions
07/02/2009US20090170772 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
07/02/2009US20090170766 Chimeric Kunitz Domains and their Use
07/02/2009US20090170763 Modified gherlin peptides
07/02/2009US20090170192 Methods and dna constructs for high yield production of polypeptides
07/02/2009US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
07/02/2009US20090170173 Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use viii
07/02/2009US20090170165 Method for recombinant production in cho cells